Back to Article List

FSSAI issues order prohibiting the use of PABA (para-amino-benzoic acid) in health supplement and nutraceutical products


Aug 01, 2020

FSSAI vide Order No Stds/Nutr(DGCI)/FSSAI-2017(Pt.1) dated 29-06-2018 (copy enclosed) has banned the use of PABA (Para Amino Benzoic Acid) in the products covered under Nutraceutical Regulations due to safety concerns with immediate effect. Pare No 2 (c) of the said order also directs the FBOs that no further manufacturing of products using this ingredient is allowed. Any product containing such ingredient which is already manufactured / imported shall be withdrawn from the market immediately. However, it has come to notice that several health supplements and nutraceutical products containing PABA are still being sold in the market as well as on e-commerce platforms.

Check the full text of the documents (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox